Why it is important to aggressively treat patients with type one antithrombin deficiency who have already experienced a clot; How he handles the treatment and management of the large cohort of ...
antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results